The resolution of the Expert Council on Interstitial Lung Diseases in Systemic Scleroderma (Moscow, October 14, 2019)

Authors :: S. N. Avdeev
L. P. Ananyeva
E. V. Zhilyaev
E. V. Zonova
A. A. Klimenko
O. A. Koneva
A. M. Lila
E. S. Pershina
A. A. Stremoukhov
S. A. Terpigorev
I. E. Tyurin
N. A. Shostak
Source :: Современная ревматология, Vol 14, Iss 1, Pp 125-128 (2020)
Publication Year :: 2020
Publisher :: IMA-PRESS LLC, 2020.
Abstract: The conclusion of the Expert Council presents the results of discussing the diagnosis and therapy of interstitial lung diseases in systemic scleroderma. The reason for this discussion was the emergence of new data on the use of nintedanib in this category of patients.

Subjects :: 030203 arthritis & rheumatology
medicine.medical_specialty
business.industry
Immunology
Systemic scleroderma
medicine.disease
Dermatology
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
030228 respiratory system
Rheumatology
chemistry
Immunology and Allergy
Medicine
Pharmacology (medical)
Nintedanib
business

Tools